Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes

BMJ Case Reports

Volumn 2018, Issue , 2018, Pages

  Viswam, Darsana ^a   Trotter, Simon ^a   Burge, P Sherwood ^a   Walters, Gareth I ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

interstitial lung disease; pneumonia (respiratory medicine)

Indexed keywords

CARBON MONOXIDE; COLECALCIFEROL; GLYCEROL; LEVOTHYROXINE; OMEPRAZOLE; PREDNISOLONE; STEROID; ANTIINFLAMMATORY AGENT; FLAVORING AGENT; PROPANEDIOL DERIVATIVE;

ADULT; ARTHRALGIA; ARTICLE; ASPIRATION PNEUMONIA; BLOOD EXAMINATION; BODY WEIGHT LOSS; BRONCHOSCOPY; CASE REPORT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; COUGHING; DIFFERENTIAL DIAGNOSIS; DYSPHAGIA; DYSPNEA; EXERCISE; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTICE; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITAL ADMISSION; HUMAN; HYPOTHYROIDISM; IRON DEFICIENCY ANEMIA; LEUKOCYTE DIFFERENTIAL COUNT; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG INFILTRATE; LUNG LAVAGE; NIGHT SWEAT; OXYGENATION; PRIORITY JOURNAL; RASH; RESPIRATORY FAILURE; SPIROMETRY; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VAPING; VIDEO ASSISTED THORACOSCOPIC SURGERY; YOUNG ADULT; COMPLICATION; DIAGNOSTIC IMAGING; ELECTRONIC CIGARETTE; LUNG; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; FLAVORING AGENTS; GLYCEROL; HUMANS; LUNG; PNEUMONIA, LIPID; PREDNISOLONE; PROPYLENE GLYCOLS; RESPIRATORY INSUFFICIENCY; TOMOGRAPHY, X-RAY COMPUTED; VAPING;

EID: 85049665544     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2018-224350     Document Type: Article

References (15)

1. Betancourt SL, Martinez-Jimenez S, Rossi SE, et al. Lipoid pneumonia: Spectrum of clinical and radiologic manifestations. AJR Am J Roentgenol 2010;194:103-9.
2. Baron SE, Haramati LB, Rivera VT. Radiological and clinical findings in acute and chronic exogenous lipoid pneumonia. J Thorac Imaging 2003;18:217-24.
3. Marchiori E, Zanetti G, Mano CM, et al. Clinical and radiological manifestations. Respir Med 2011;105:659-66.
4. Gondouin A, Manzoni P, Ranfaing E, et al. Exogenous lipid pneumonia: A retrospective multicentre study of 44 cases in France. Eur Respir J 1996;9:1463-9.
5. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest 2012;141:1110-3.
6. Modi S, Sangani R, Alhajhusain A. Acute lipoid pneumonia secondary to e-cigarettes use: An unlikely replacement for cigarettes. Chest 2015;148:382A.
7. Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring chemicals in e-cigarettes: Diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect 2016;124:733-9.
8. Kreiss K, Gomaa A, Kullman G, et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 2002;347:330-8.
9. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 2014;20:218-25.
10. AS H. Use of electronic cigarettes (vapourisers) among adults in Great Britain. http://ash. org. uk/information-A nd-resources/fact-sheets/use-of-e-cigarettes-A mong-A dultsin-great-britain-2017/(accessed 3 Jan 2018).
11. P ublic Health England. E-cigarettes: An evidence update. London: Public Health England, 2015.
12. Smoking in England. Smoking toolkit study: Trends in electronic cigarette use in England. 2015 (accessed 3 Jan 2018).
13. Brown J, Beard E, Kotz D, et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: A cross-sectional population study. Addiction 2014;109:1531-40.
14. McRobbie H, Bullen C, Hartmann-Boyce J, et al. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;12:CD010216.
15. Chun LF, Moazed F, Calfee CS, et al. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol 2017;313:L193-L206.